Viewing Study NCT01840566


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-02-01 @ 11:23 AM
Study NCT ID: NCT01840566
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2013-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module